A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia

Feng Yan; Nicholas C. Wong; David R. Powell; David J. Curtis

doi:10.1038/s41375-020-0888-8

A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia

Feng Yan, Nicholas C. Wong, David R. Powell, David J. Curtis

Research output: Contribution to journal › Letter › Research › peer-review

Original language	English
Pages (from-to)	3070–3074
Number of pages	5
Journal	Leukemia
Volume	34
Issue number	11
DOIs	https://doi.org/10.1038/s41375-020-0888-8
Publication status	Published - Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41375-020-0888-8

Cite this

@article{1ea8ed390d064f03848f77b9be86e243,

title = "A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia",

author = "Feng Yan and Wong, {Nicholas C.} and Powell, {David R.} and Curtis, {David J.}",

year = "2020",

month = nov,

doi = "10.1038/s41375-020-0888-8",

language = "English",

volume = "34",

pages = "3070–3074",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia

AU - Yan, Feng

AU - Wong, Nicholas C.

AU - Powell, David R.

AU - Curtis, David J.

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85085957448&partnerID=8YFLogxK

U2 - 10.1038/s41375-020-0888-8

DO - 10.1038/s41375-020-0888-8

M3 - Letter

C2 - 32488116

AN - SCOPUS:85085957448

SN - 0887-6924

VL - 34

SP - 3070

EP - 3074

JO - Leukemia

JF - Leukemia

IS - 11

ER -

A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia

UN SDGs

Access to Document

Other files and links

Curing blood cancers: rapid translation from target to drug to clinic

Cite this

A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia

UN SDGs

Access to Document

Other files and links

Projects

Curing blood cancers: rapid translation from target to drug to clinic

Cite this